CLINICAL ECONOMIC ANALYSIS OF USING ERIBULIN (HALAVEN®) FOR TREATMENT OF PATIENTS WITH METASTATIC BREAST CANCER
Breast cancer is the most common cause of death from cancer among women in Russia. More than half of patients have metastases at diagnosis. Chemotherapy is an important component of combined modality treatment for breast cancer. The budget impact analysis of expenses for the use of eribulina demonst...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Russian Academy of Sciences, Tomsk National Research Medical Center
2016-02-01
|
| Series: | Сибирский онкологический журнал |
| Subjects: | |
| Online Access: | https://www.siboncoj.ru/jour/article/view/268 |
| _version_ | 1797875914450665472 |
|---|---|
| author | S. L. Plavinsky P. I. Shabalkin |
| author_facet | S. L. Plavinsky P. I. Shabalkin |
| author_sort | S. L. Plavinsky |
| collection | DOAJ |
| description | Breast cancer is the most common cause of death from cancer among women in Russia. More than half of patients have metastases at diagnosis. Chemotherapy is an important component of combined modality treatment for breast cancer. The budget impact analysis of expenses for the use of eribulina demonstrated that its inclusion in the «List of Essential Drugs» greatly expand the possibilities of treatment for metastatic breast cancer without causing significant additional burden on the health budget of the Russian Federation. |
| first_indexed | 2024-04-10T01:54:00Z |
| format | Article |
| id | doaj.art-24ea0483afb54dc0a14e0f7a785405b9 |
| institution | Directory Open Access Journal |
| issn | 1814-4861 2312-3168 |
| language | Russian |
| last_indexed | 2024-04-10T01:54:00Z |
| publishDate | 2016-02-01 |
| publisher | Russian Academy of Sciences, Tomsk National Research Medical Center |
| record_format | Article |
| series | Сибирский онкологический журнал |
| spelling | doaj.art-24ea0483afb54dc0a14e0f7a785405b92023-03-13T09:05:48ZrusRussian Academy of Sciences, Tomsk National Research Medical CenterСибирский онкологический журнал1814-48612312-31682016-02-01051723268CLINICAL ECONOMIC ANALYSIS OF USING ERIBULIN (HALAVEN®) FOR TREATMENT OF PATIENTS WITH METASTATIC BREAST CANCERS. L. Plavinsky0P. I. Shabalkin1ГБОУ ВПО «СЗГМУ им. И.И. Мечникова» МЗ РФ, г. Санкт-ПетербургФГБУ «ФНКЦ ДГОИ им. Дмитрия Рогачева» МЗ РФ, г. МоскваBreast cancer is the most common cause of death from cancer among women in Russia. More than half of patients have metastases at diagnosis. Chemotherapy is an important component of combined modality treatment for breast cancer. The budget impact analysis of expenses for the use of eribulina demonstrated that its inclusion in the «List of Essential Drugs» greatly expand the possibilities of treatment for metastatic breast cancer without causing significant additional burden on the health budget of the Russian Federation.https://www.siboncoj.ru/jour/article/view/268рак молочной железыэрибулинанализ влияния на бюджет |
| spellingShingle | S. L. Plavinsky P. I. Shabalkin CLINICAL ECONOMIC ANALYSIS OF USING ERIBULIN (HALAVEN®) FOR TREATMENT OF PATIENTS WITH METASTATIC BREAST CANCER Сибирский онкологический журнал рак молочной железы эрибулин анализ влияния на бюджет |
| title | CLINICAL ECONOMIC ANALYSIS OF USING ERIBULIN (HALAVEN®) FOR TREATMENT OF PATIENTS WITH METASTATIC BREAST CANCER |
| title_full | CLINICAL ECONOMIC ANALYSIS OF USING ERIBULIN (HALAVEN®) FOR TREATMENT OF PATIENTS WITH METASTATIC BREAST CANCER |
| title_fullStr | CLINICAL ECONOMIC ANALYSIS OF USING ERIBULIN (HALAVEN®) FOR TREATMENT OF PATIENTS WITH METASTATIC BREAST CANCER |
| title_full_unstemmed | CLINICAL ECONOMIC ANALYSIS OF USING ERIBULIN (HALAVEN®) FOR TREATMENT OF PATIENTS WITH METASTATIC BREAST CANCER |
| title_short | CLINICAL ECONOMIC ANALYSIS OF USING ERIBULIN (HALAVEN®) FOR TREATMENT OF PATIENTS WITH METASTATIC BREAST CANCER |
| title_sort | clinical economic analysis of using eribulin halaven r for treatment of patients with metastatic breast cancer |
| topic | рак молочной железы эрибулин анализ влияния на бюджет |
| url | https://www.siboncoj.ru/jour/article/view/268 |
| work_keys_str_mv | AT slplavinsky clinicaleconomicanalysisofusingeribulinhalavenfortreatmentofpatientswithmetastaticbreastcancer AT pishabalkin clinicaleconomicanalysisofusingeribulinhalavenfortreatmentofpatientswithmetastaticbreastcancer |